Brief: Idera Pharmaceuticals Reports Qtrly Loss Per Share $0.10
09/08/2022 23:00
Aug 9 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS
* IDERA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nGNX4RsptR
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary